Skip to main content
Invitae, Alnylam to Provide Free Genetic Testing for Primary Hyperoxaluria
Invitae announced today that it is partnering with RNAi therapeutics firm Alnylam Pharmaceuticals to provide free genetic testing to improve diagnosis and management of a rare inherited disorder called primary hyperoxaluria.
Subscribe to Genetic testing